Cargando…
Clinical study of Arogyavardhini compound and lifestyle modification in management of metabolic syndrome: A double‑blind placebo controlled randomized clinical trial
BACKGROUND: Metabolic syndrome (MS) is a cluster of obesity, hypertriglyceridemia, impaired glucose tolerance, and insulin resistance. The sedentary lifestyle settles on the phenotypical expression of a genetically acquired trait in an obese person. Weight control and a healthy lifestyle remain prim...
Autores principales: | Padhar, Bharatkumar Chhaganbhai, Dave, Alankruta R., Goyal, Mandip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685257/ https://www.ncbi.nlm.nih.gov/pubmed/33281394 http://dx.doi.org/10.4103/ayu.AYU_79_19 |
Ejemplares similares
-
Efficacy of Vyoshadi Guggulu and Shadushana Churna in the management of subclinical hypothyroidism: An open labelled randomized comparative pilot clinical trial
por: Sharma, Vidhya Bharti, et al.
Publicado: (2020) -
Efficacy of Sharapunkhadi powder (a polyherbal formulation) and lifestyle modification in the management of nonalcoholic fatty liver disease-A randomized placebo-controlled clinical trial
por: Remya, E., et al.
Publicado: (2020) -
Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study
por: Kumar, Gajendra, et al.
Publicado: (2012) -
The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate
por: Kumar, Gajendra, et al.
Publicado: (2013) -
A clinical study of some Ayurvedic compound drugs in the assessment quality of life of patients with Eka Kushtha (psoriasis)
por: Mehta, Charmi S, et al.
Publicado: (2011)